787 related articles for article (PubMed ID: 18487007)
41. [Synchronous bilateral renal cell cancer with a single ovarian metastasis and a fibromuscular dysplasia of the renal artery].
Madersbacher S; Ponholzer A; Franz K; Höltl W
Aktuelle Urol; 2007 Jan; 38(1):52-4. PubMed ID: 17290330
[TBL] [Abstract][Full Text] [Related]
42. Laparoscopic and open partial nephrectomy: a matched-pair comparison of 200 patients.
Marszalek M; Meixl H; Polajnar M; Rauchenwald M; Jeschke K; Madersbacher S
Eur Urol; 2009 May; 55(5):1171-8. PubMed ID: 19232819
[TBL] [Abstract][Full Text] [Related]
43. PD-1 is expressed by tumor-infiltrating immune cells and is associated with poor outcome for patients with renal cell carcinoma.
Thompson RH; Dong H; Lohse CM; Leibovich BC; Blute ML; Cheville JC; Kwon ED
Clin Cancer Res; 2007 Mar; 13(6):1757-61. PubMed ID: 17363529
[TBL] [Abstract][Full Text] [Related]
44. Management of bilateral synchronous renal cell carcinoma in a single versus staged procedure.
Jacobs BL; Gibbons EP; Gayed BA; Whetstone JL; Hrebinko RL
Can J Urol; 2009 Feb; 16(1):4507-11. PubMed ID: 19222893
[TBL] [Abstract][Full Text] [Related]
45. The influence of clinical and pathological stage discrepancy on cancer specific survival in patients treated for renal cell carcinoma.
Svatek RS; Lotan Y; Herman MP; Duchene DA; Sagalowsky AI; Cadeddu JA
J Urol; 2006 Oct; 176(4 Pt 1):1321-5; discussion 125. PubMed ID: 16952621
[TBL] [Abstract][Full Text] [Related]
46. Young age is independent prognostic factor for cancer-specific survival of low-stage clear cell renal cell carcinoma.
Jung EJ; Lee HJ; Kwak C; Ku JH; Moon KC
Urology; 2009 Jan; 73(1):137-41. PubMed ID: 18950844
[TBL] [Abstract][Full Text] [Related]
47. Surgical resection provides excellent outcomes for patients with cystic clear cell renal cell carcinoma.
Webster WS; Thompson RH; Cheville JC; Lohse CM; Blute ML; Leibovich BC
Urology; 2007 Nov; 70(5):900-4; discussion 904. PubMed ID: 18068445
[TBL] [Abstract][Full Text] [Related]
48. [The surgical treatment and prognosis of bilateral sporadic renal tumors].
Zhang N; Gong K; Zhou LQ; Yang Y; Na YQ
Zhonghua Wai Ke Za Zhi; 2007 Jan; 45(2):121-3. PubMed ID: 17418042
[TBL] [Abstract][Full Text] [Related]
49. Outcome of nephron-sparing surgery for T1b renal cell carcinoma.
Joniau S; Vander Eeckt K; Srirangam SJ; Van Poppel H
BJU Int; 2009 May; 103(10):1344-8. PubMed ID: 19040528
[TBL] [Abstract][Full Text] [Related]
50. Survival after resection of synchronous bilateral lung cancer.
De Leyn P; Moons J; Vansteenkiste J; Verbeken E; Van Raemdonck D; Nafteux P; Decaluwe H; Lerut T
Eur J Cardiothorac Surg; 2008 Dec; 34(6):1215-22. PubMed ID: 18829338
[TBL] [Abstract][Full Text] [Related]
51. Frequency and clinical features of multiple tumors of the large bowel in the general population and in patients with hereditary colorectal carcinoma.
Fante R; Roncucci L; Di GregorioC ; Tamassia MG; Losi L; Benatti P; Pedroni M; Percesepe A; De Pietri S; Ponz de Leon M
Cancer; 1996 May; 77(10):2013-21. PubMed ID: 8640664
[TBL] [Abstract][Full Text] [Related]
52. The preoperative erythrocyte sedimentation rate is an independent prognostic factor in renal cell carcinoma.
Sengupta S; Lohse CM; Cheville JC; Leibovich BC; Thompson RH; Webster WS; Frank I; Zincke H; Blute ML; Kwon ED
Cancer; 2006 Jan; 106(2):304-12. PubMed ID: 16353202
[TBL] [Abstract][Full Text] [Related]
53. Influence of tumour-associated symptoms on the prognosis of patients with renal cell carcinoma.
Kawaciuk I; Hyrsl L; Dusek P; Jarolim L; Schmidt M; Kaliska V; Chocholaty M; Vesely S
Scand J Urol Nephrol; 2008; 42(5):406-11. PubMed ID: 18932106
[TBL] [Abstract][Full Text] [Related]
54. Impact of several histopathological prognosticators and local tumour extension on oncological outcome in pT3b/c N0M0 renal cell carcinoma.
Roos FC; Weirich J; Victor A; Elsässer A; Brenner W; Biesterfeld S; Hampel C; Thüroff JW
BJU Int; 2009 Aug; 104(4):461-9. PubMed ID: 19338563
[TBL] [Abstract][Full Text] [Related]
55. [Metachronous or contralateral adrenal metastases in renal cell cancer].
Gross AJ; Dieckmann KP; Huland H
Urologe A; 1993 Jul; 32(4):286-9. PubMed ID: 8372409
[TBL] [Abstract][Full Text] [Related]
56. Unclassified renal cell carcinoma: impact on survival following nephrectomy.
Crispen PL; Tabidian MR; Allmer C; Lohse CM; Breau RH; Blute ML; Cheville JC; Leibovich BC
Urology; 2010 Sep; 76(3):580-6. PubMed ID: 20223503
[TBL] [Abstract][Full Text] [Related]
57. [Bilateral breast carcinoma. 12 years' experience].
Maculotti L; Gandini F; Pradella P
Minerva Chir; 1996; 51(1-2):33-7. PubMed ID: 8677043
[TBL] [Abstract][Full Text] [Related]
58. Multiple primary malignancies in patients with renal cell carcinoma: a national population-based cohort study.
Beisland C; Talleraas O; Bakke A; Norstein J
BJU Int; 2006 Apr; 97(4):698-702. PubMed ID: 16536756
[TBL] [Abstract][Full Text] [Related]
59. Comparison of type I and II papillary renal cell carcinoma (RCC) and clear cell RCC.
Waldert M; Haitel A; Marberger M; Katzenbeisser D; Ozsoy M; Stadler E; Remzi M
BJU Int; 2008 Nov; 102(10):1381-4. PubMed ID: 18782311
[TBL] [Abstract][Full Text] [Related]
60. Outcomes following partial nephrectomy by tumor size.
Crispen PL; Boorjian SA; Lohse CM; Sebo TS; Cheville JC; Blute ML; Leibovich BC
J Urol; 2008 Nov; 180(5):1912-7. PubMed ID: 18801543
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]